AUD 0.03
(-5.71%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 28.04 Million AUD | 205.06% |
2023 | 9.19 Million AUD | 16.69% |
2022 | 7.87 Million AUD | -27.17% |
2021 | 10.81 Million AUD | -14.32% |
2020 | 12.62 Million AUD | -53.63% |
2019 | 27.22 Million AUD | -9.19% |
2018 | 29.97 Million AUD | -6.83% |
2017 | 32.17 Million AUD | 6.03% |
2016 | 30.34 Million AUD | 64.91% |
2015 | 18.4 Million AUD | 74.49% |
2014 | 10.54 Million AUD | 3.23% |
2013 | 10.21 Million AUD | -32.55% |
2012 | 15.14 Million AUD | -13.38% |
2011 | 17.48 Million AUD | 27.42% |
2010 | 13.72 Million AUD | -12.76% |
2009 | 15.72 Million AUD | 37.3% |
2008 | 11.45 Million AUD | 0.0% |
2007 | - AUD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 4.25 Million AUD | 0.0% |
2024 FY | 9.99 Million AUD | 8.77% |
2024 Q4 | -5.67 Million AUD | 0.0% |
2023 Q2 | 4.76 Million AUD | 0.0% |
2023 FY | 9.19 Million AUD | 16.69% |
2023 Q4 | 4.05 Million AUD | 0.0% |
2022 Q4 | 4.18 Million AUD | 0.0% |
2022 FY | 7.87 Million AUD | -27.17% |
2022 Q2 | 3.59 Million AUD | 0.0% |
2021 Q4 | 5.43 Million AUD | 0.0% |
2021 Q2 | 5.35 Million AUD | 0.0% |
2021 FY | 10.81 Million AUD | -14.32% |
2020 Q2 | 8.01 Million AUD | 0.0% |
2020 Q4 | 4.41 Million AUD | 0.0% |
2020 FY | 12.62 Million AUD | -53.63% |
2019 Q4 | 6.52 Million AUD | 0.0% |
2019 Q2 | 13.48 Million AUD | 0.0% |
2019 FY | 27.22 Million AUD | -9.19% |
2018 Q2 | 15.7 Million AUD | 0.0% |
2018 FY | 29.97 Million AUD | -6.83% |
2018 Q4 | 14.26 Million AUD | 0.0% |
2017 FY | 32.17 Million AUD | 6.03% |
2017 Q2 | 16.08 Million AUD | 0.0% |
2017 Q4 | 16.09 Million AUD | 0.0% |
2016 Q4 | 17.1 Million AUD | 0.0% |
2016 FY | 30.34 Million AUD | 64.91% |
2016 Q2 | 13.23 Million AUD | 0.0% |
2015 FY | 18.4 Million AUD | 74.49% |
2015 Q2 | 7.64 Million AUD | 0.0% |
2015 Q4 | 10.76 Million AUD | 0.0% |
2014 Q4 | 5.76 Million AUD | 0.0% |
2014 FY | 10.54 Million AUD | 3.23% |
2014 Q2 | 4.78 Million AUD | 0.0% |
2013 Q2 | 6.04 Million AUD | 0.0% |
2013 Q4 | 4.17 Million AUD | 0.0% |
2013 FY | 10.21 Million AUD | -32.55% |
2012 Q3 | 848.5 Thousand AUD | 0.0% |
2012 FY | 15.14 Million AUD | -13.38% |
2012 Q2 | 848.5 Thousand AUD | -5.01% |
2012 Q1 | 893.25 Thousand AUD | 0.0% |
2012 Q4 | - AUD | -100.0% |
2011 Q1 | 887.25 Thousand AUD | 0.0% |
2011 Q2 | 893.25 Thousand AUD | 0.68% |
2011 Q4 | - AUD | -100.0% |
2011 FY | 17.48 Million AUD | 27.42% |
2011 Q3 | 893.25 Thousand AUD | 0.0% |
2010 Q4 | - AUD | -100.0% |
2010 Q3 | 887.25 Thousand AUD | 0.0% |
2010 FY | 13.72 Million AUD | -12.76% |
2010 Q2 | 887.25 Thousand AUD | -26.97% |
2010 Q1 | 1.21 Million AUD | 0.0% |
2009 Q3 | 1.21 Million AUD | 0.0% |
2009 Q4 | - AUD | -100.0% |
2009 Q2 | 1.21 Million AUD | 23.3% |
2009 Q1 | 985.41 Thousand AUD | 0.0% |
2009 FY | 15.72 Million AUD | 37.3% |
2008 Q4 | - AUD | -100.0% |
2008 Q2 | 985.41 Thousand AUD | 0.0% |
2008 Q1 | - AUD | 0.0% |
2008 FY | 11.45 Million AUD | 0.0% |
2008 Q3 | 985.41 Thousand AUD | 0.0% |
2007 Q3 | - AUD | 0.0% |
2007 Q4 | - AUD | 0.0% |
2007 FY | - AUD | 0.0% |
2007 Q2 | - AUD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | 10.935% |
Adherium Limited | 267.7 Thousand AUD | -10374.668% |
Aroa Biosurgery Limited | 66.09 Million AUD | 57.578% |
Atomo Diagnostics Limited | 1.6 Million AUD | -1646.012% |
Anteris Technologies Ltd | 69.14 Million AUD | 59.449% |
Control Bionics Limited | 9.82 Million AUD | -185.378% |
CardieX Limited | 16.64 Million AUD | -68.425% |
Compumedics Limited | 26.88 Million AUD | -4.319% |
Cochlear Limited | 1.17 Billion AUD | 97.613% |
CleanSpace Holdings Limited | 11.35 Million AUD | -146.855% |
Cyclopharm Limited | 13.38 Million AUD | -109.561% |
EMVision Medical Devices Ltd | 12.83 Million AUD | -118.497% |
Nova Eye Medical Limited | 23.99 Million AUD | -16.886% |
HeraMED Limited | 6.78 Million AUD | -313.404% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 2612.997% |
InhaleRx Limited | 2.59 Million AUD | -982.441% |
LBT Innovations Limited | 1.1 Million AUD | -2433.062% |
Micro-X Limited | 18.76 Million AUD | -49.44% |
Neurotech International Limited | 8.75 Million AUD | -220.311% |
OncoSil Medical Limited | 12.03 Million AUD | -132.902% |
PolyNovo Limited | 34.92 Million AUD | 19.704% |
Respiri Limited | 8.03 Million AUD | -248.992% |
SomnoMed Limited | 58.97 Million AUD | 52.451% |
Universal Biosensors, Inc. | 20 Million AUD | -40.203% |
Uscom Limited | 5.52 Million AUD | -407.985% |
Visioneering Technologies, Inc. | 9.63 Million AUD | -191.074% |